EUVIMEDEUVIMED entdecken
Leserbrief

TP63 ‐rearranged ALK ‐negative anaplastic large‐cell lymphoma post‐transplant lymphoproliferative disorder: the first report of an aggressive entity

Frances Zhao iD, Jenna Cox, Peter Mollee, Greg Hapgood

Internal Medicine Journal · 2026-03 · 56 (3) · 499-501

DOI: 10.1111/imj.70331 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Internal Medicine Journal, online erschienen am 05.03.2026. Verfasst von Frances Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia. Die Arbeit nennt 12 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • School of Medicine, University of Queensland, Brisbane, Queensland, Australia.

ORCID-Profile: Frances Zhao

Zitieren

APA

Zhao, F., Cox, J., Mollee, P., & Hapgood, G. (2026). TP63 ‐rearranged ALK ‐negative anaplastic large‐cell lymphoma post‐transplant lymphoproliferative disorder: the first report of an aggressive entity. Internal Medicine Journal, 56(3), 499-501. https://doi.org/10.1111/imj.70331

Vancouver

Zhao F, Cox J, Mollee P, Hapgood G. TP63 ‐rearranged ALK ‐negative anaplastic large‐cell lymphoma post‐transplant lymphoproliferative disorder: the first report of an aggressive entity. Internal Medicine Journal. 2026;56(3):499-501. doi:10.1111/imj.70331

BibTeX
@article{Zhao2026,
  author = {Zhao, Frances and Cox, Jenna and Mollee, Peter and Hapgood, Greg},
  title = {TP63 ‐rearranged ALK ‐negative anaplastic large‐cell lymphoma post‐transplant lymphoproliferative disorder: the first report of an aggressive entity},
  journal = {Internal Medicine Journal},
  year = {2026},
  volume = {56},
  number = {3},
  pages = {499--501},
  doi = {10.1111/imj.70331}
}
Kostenlos starten →